Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annick Rousseau

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 13, 2005
Tacrolimus pharmacokinetics and dose monitoring after lung transplantation for cystic fibrosis and other conditionsChristiane Knoop, Philippe Thiry, Franck Saint-Marcoux, et al.
Pharmacogenetics and Genomics|August 7, 2012
Association of sirolimus adverse effects with m-TOR, p70S6K or Raptor polymorphisms in kidney transplant recipientsJean-Baptiste Woillard, Nassim Kamar, Annick Rousseau, et al.
Toxicology and Applied Pharmacology|October 18, 2002
An animal model for the study of chronopharmacokinetics of drugs and application to methotrexate and vinorelbineAurélie Prémaud, Annick Rousseau, Mireille Gicquel, et al.
Clinical Pharmacokinetics|October 31, 2002
Bayesian estimation of methotrexate pharmacokinetic parameters and area under the curve in children and young adults with localised osteosarcomaAnnick Rousseau, Christophe Sabot, Nicole Delepine, et al.
Therapeutic Drug Monitoring|March 11, 2010
Stability of ribavirin concentrations depending on the type of blood collection tube and preanalytical conditionsPierre Marquet, François-Ludovic Sauvage, Véronique Loustaud-Ratti, et al.
Clinical Pharmacokinetics|December 24, 2005
Pharmacokinetic study of tacrolimus in cystic fibrosis and non-cystic fibrosis lung transplant patients and design of Bayesian estimators using limited sampling strategiesFranck Saint-Marcoux, Christiane Knoop, Jean Debord, et al.
Journal of Transplantation|May 17, 2019
A Prognostic Tool for Individualized Prediction of Graft Failure Risk within Ten Years after Kidney TransplantationDanko Stamenic, Annick Rousseau, Marie Essig, et al.
Clinical Pharmacokinetics|October 20, 2006
Sirolimus population pharmacokinetic/pharmacogenetic analysis and bayesian modelling in kidney transplant recipientsNassim Djebli, Annick Rousseau, Guillaume Hoizey, et al.
British Journal of Clinical Pharmacology|February 3, 2011
Population pharmacokinetic model and Bayesian estimator for two tacrolimus formulations--twice daily Prograf and once daily AdvagrafJean-Baptiste Woillard, Brenda C M de Winter, Nassim Kamar, et al.
Clinical Pharmacokinetics|February 5, 2002
Maximum a posteriori Bayesian estimation of oral cyclosporin pharmacokinetics in patients with stable renal transplantsFrédéric Leger, Jean Debord, Yann Le Meur, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 13, 2005
Tacrolimus pharmacokinetics and dose monitoring after lung transplantation for cystic fibrosis and other conditionsChristiane Knoop, Philippe Thiry, Franck Saint-Marcoux, et al.
Pharmacogenetics and Genomics|August 7, 2012
Association of sirolimus adverse effects with m-TOR, p70S6K or Raptor polymorphisms in kidney transplant recipientsJean-Baptiste Woillard, Nassim Kamar, Annick Rousseau, et al.
Toxicology and Applied Pharmacology|October 18, 2002
An animal model for the study of chronopharmacokinetics of drugs and application to methotrexate and vinorelbineAurélie Prémaud, Annick Rousseau, Mireille Gicquel, et al.
Clinical Pharmacokinetics|October 31, 2002
Bayesian estimation of methotrexate pharmacokinetic parameters and area under the curve in children and young adults with localised osteosarcomaAnnick Rousseau, Christophe Sabot, Nicole Delepine, et al.
Therapeutic Drug Monitoring|March 11, 2010
Stability of ribavirin concentrations depending on the type of blood collection tube and preanalytical conditionsPierre Marquet, François-Ludovic Sauvage, Véronique Loustaud-Ratti, et al.
Clinical Pharmacokinetics|December 24, 2005
Pharmacokinetic study of tacrolimus in cystic fibrosis and non-cystic fibrosis lung transplant patients and design of Bayesian estimators using limited sampling strategiesFranck Saint-Marcoux, Christiane Knoop, Jean Debord, et al.
Journal of Transplantation|May 17, 2019
A Prognostic Tool for Individualized Prediction of Graft Failure Risk within Ten Years after Kidney TransplantationDanko Stamenic, Annick Rousseau, Marie Essig, et al.
Clinical Pharmacokinetics|October 20, 2006
Sirolimus population pharmacokinetic/pharmacogenetic analysis and bayesian modelling in kidney transplant recipientsNassim Djebli, Annick Rousseau, Guillaume Hoizey, et al.
British Journal of Clinical Pharmacology|February 3, 2011
Population pharmacokinetic model and Bayesian estimator for two tacrolimus formulations--twice daily Prograf and once daily AdvagrafJean-Baptiste Woillard, Brenda C M de Winter, Nassim Kamar, et al.
Clinical Pharmacokinetics|February 5, 2002
Maximum a posteriori Bayesian estimation of oral cyclosporin pharmacokinetics in patients with stable renal transplantsFrédéric Leger, Jean Debord, Yann Le Meur, et al.
Pageof 5